Cargando…
T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?
Pancreatic cancer is an aggressive and potent disease, which is largely resistant to conventional forms of treatment. However, the discovery of antigens associated with pancreatic cancer cells has recently suggested the possibility that immunotherapy might become a specific and effective therapeutic...
Autores principales: | French, J J, Cresswell, J, Wong, W K, Seymour, K, Charnley, R M, Kirby, J A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364324/ https://www.ncbi.nlm.nih.gov/pubmed/12434297 http://dx.doi.org/10.1038/sj.bjc.6600597 |
Ejemplares similares
-
Soluble E-Cadherin: An Early Marker of Severity in Acute Pancreatitis
por: Sewpaul, A., et al.
Publicado: (2009) -
Selective disruption of the E-cadherin–catenin system by an algal toxin
por: Ronzitti, G, et al.
Publicado: (2004) -
Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy
por: Atkins, H, et al.
Publicado: (2003) -
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
por: Lombaerts, M, et al.
Publicado: (2006) -
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides
por: Lau, J P, et al.
Publicado: (2004)